Drug-eluting bead transarterial chemoembolization combined with cryoablation for renal cell carcinoma Yixuan ChengQiang XuLongzhen Piao case report 13 June 2025
Nutritional changes and problems with food intake in cancer patients undergoing chemotherapy treatment: detailed analysis of associated symptoms Anna Patrícia Santos CardosoAnne Queiroz MadureiraPriscila Bernardina Miranda Soares original report 10 June 2025
Proposed prognostic score including circulating free DNA concentration in diffuse large B-cell lymphoma Esraa JamalMohamed ElbogdadySameh Shamaah original report 10 June 2025
Epidermal radionuclide therapy with 188rhenium—the new treatment for skin squamous cell carcinoma Mina AshjaeiSiroos Mirzaei short review 06 June 2025
Optimizing disease risk stratification and clinical outcomes in chronic lymphocytic leukemia 2025 Jan-Paul Bohn editorial 21 May 2025 Pages: 69 - 70
Best of ESMO 2024: gynecologic cancers Stephan Polterauer short review Open access 12 May 2025 Pages: 71 - 74
Blinatumomab is changing the standard of care paradigms of newly diagnosed and relapsed pediatric B-cell acute lymphoblastic leukemia Andishe AttarbaschiFiona Poyer short review Open access 07 May 2025 Pages: 104 - 107
A short review on the current status of PSMA ligands used for PSMA-PET/CT imaging Lilit SchweigerIrene Virgolini short review Open access 07 May 2025
Current and future pharmacological therapies for extensive-stage small-cell lung cancer Johannes SchöcheAriane SteindlBarbara Kiesewetter short review Open access 28 April 2025 Pages: 116 - 124
Mind the gap in clinical practice guidelines—how I treat CLL patients with unmutated IGHV status Katharina Prochazka short review Open access 24 April 2025 Pages: 97 - 100
The management of modern targeted therapy for CLL in a patient with significant cardiac comorbidities—a case report Thomas Spanberger case report 22 April 2025 Pages: 101 - 103
Best of ESMO: pan-tumor highlights Thorsten Füreder short review Open access 22 April 2025 Pages: 82 - 85
Too frail or not too frail? Prognosis and treatment options in older CLL patients Florian Simon short review Open access 17 April 2025 Pages: 92 - 96
EffiXane—Non-interventional study on safety and effectiveness of nab-paclitaxel (Abraxane®) + gemcitabine as first-line treatment of metastatic PDAC in a daily routine setting Magdalena WojtasikR.-B. KuehnC. Constantin original report 16 April 2025
Evaluating antifungal prophylaxis strategies in pediatric acute myeloid leukemia: a retrospective, single-center analysis of amphotericin B, itraconazole, and voriconazole Anna CvrtakHeidrun BoztugMichael N. Dworzak original report Open access 15 April 2025 Pages: 142 - 149
Prognostic tools and risk factors in early-stage CLL—time for a change in treatment paradigm? Martyna BartkowiakManuela A. Hoechstetter short review 14 April 2025 Pages: 86 - 91
ESMO 2024: highlights in breast cancer Simon UdovicaMuna FernerRupert Bartsch short review Open access 14 April 2025 Pages: 75 - 79
Diffuse large B-cell lymphoma of the right upper extremity misdiagnosed as soft tissue infection Lipeng CaoDanbo Cao case report 02 April 2025
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology Abstracts OeGHO/OPG 01 April 2025 Pages: 1 - 27
Placement of port-a-cath systems via the jugular vein: a surgical perspective Claudia Bartsch editorial 07 February 2025 Pages: 3 - 3
ASCO highlights: neoadjuvant immunotherapy in mismatch repair deficient colorectal cancer Gudrun Piringer short review Open access 31 January 2025 Pages: 26 - 29
Endometrial cancer—news from ASCO 2024 Edgar PetruMarina SchinnerlVassiliki Kolovetsiou short review Open access 31 January 2025 Pages: 19 - 21
Biomarkers and treatment updates in renal cell carcinoma Jasmin Alija Spiegelberg short review 30 January 2025 Pages: 30 - 33
Oligometastatic breast cancer from the perspective of the radiation oncologist Stefan Konrad review Open access 16 January 2025 Pages: 38 - 41
Highlights on gastroesophageal tumors: the comeback of FLOT Aysegul Ilhan-Mutlu short review Open access 14 January 2025 Pages: 34 - 37
Local treatment strategies in oligometastatic colorectal cancer Alexander Kupferthaler short review Open access 11 January 2025 Pages: 45 - 48
Advances in pancreatic cancer treatment Hossein Taghizadeh short review Open access 09 January 2025 Pages: 22 - 25
CRLF2 expression associated with poor outcome in Philadelphia-negative acute lymphoblastic leukemia Amal M. El-AfifiNermeen A. NabihHaydi S. Mohamed original report 30 December 2024 Pages: 129 - 135
Evolving treatment paradigms after CDK4/6 inhibitors in advanced breast cancer Michael GnantMarija BalicRupert Bartsch review Open access 20 December 2024 Pages: 4 - 18
Rare case of human epidermal growth factor receptor 2-positive gastric remnant cancer after bariatric surgery—case report Carolin-Sophie WagnerMelanie SchartnerMichael Schnallinger case report Open access 18 December 2024 Pages: 63 - 67
Personalized decision making of neoadjuvant chemotherapy vs. upfront surgery in pancreatic cancer by a simple blood collection? Patrick KirchwegerBernhard DoleschalMatthias Biebl short review Open access 18 December 2024 Pages: 49 - 52
JAK2 mutations in polycythemia vera: from molecular origins to inflammatory pathways and clinical implications Beatriz BellosilloMichael DoubekHeinz Gisslinger position paper Open access 10 December 2024 Pages: 79 - 93
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES Report from the American Society of Hematology (ASH) Annual Meeting, December 7–10, 2024 Congress Report ASH 2024 21 January 2025 Pages: 97 - 119
Report from the ASH annual meeting Stephan StilgenbauerAnna Fenzl editorial 24 January 2025 Pages: 95 - 96
Not only a chicken and egg problem in children with pancytopenia Michael N. Dworzak editorial 29 November 2024 Pages: 240 - 241
KRAS: Finally a druggable target in oncology? Aysegul Ilhan-Mutlu editorial 29 November 2024 Pages: 239 - 239
Locoregional therapy of oligometastatic breast cancer Florian Fitzal short review Open access 26 November 2024 Pages: 42 - 44
Unraveling (K)RAS in pancreatic ductal adenocarcinoma Bernhard Doleschal short review Open access 21 November 2024 Pages: 292 - 296
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer, September 7th –10th , hybrid congress Congress Report WCLC 2024 14 November 2024 Pages: 61 - 78
Impact of the WHO-5 classification of haematolymphoid tumours on clinical practice Rosa BrandIngrid Simonitsch-Klupp short review Open access 12 November 2024 Pages: 269 - 273
State-of-the-art therapy and innovative treatment strategies in esophageal squamous cell cancer Martin KorpanHannah Christina PuhrAysegül Ilhan-Mutlu short review Open access 11 November 2024 Pages: 274 - 279
Recent developments in marginal zone lymphoma Markus RadererBarbara Kiesewetter short review Open access 04 November 2024 Pages: 247 - 250
Implantable catheter chambers: a 14-year descriptive study Anas ErraghSalma BellaftouhRachid Alharrar original report 30 October 2024 Pages: 56 - 62
BACE (Bendamustine, Cytarabine, Cyclophosphamide and Etoposide) conditioning regime for patients with lymphoma undergoing autologous stem cell transplant Joydeep ChakrabarttyArijit BishnuKeisam Sanjita Devi original report 28 October 2024 Pages: 136 - 141
Next generation of drugs in breast cancer Rupert Bartsch short review Open access 24 October 2024 Pages: 280 - 286
Treatment sequencing in gastroenteropancreatic neuroendocrine tumors Philipp MelhornMarkus RadererBarbara Kiesewetter short review Open access 23 October 2024 Pages: 257 - 262
Escalation of neoadjuvant therapy in triple-negative breast cancer—balancing effectiveness and toxicities Christoph Suppan short review Open access 23 October 2024 Pages: 251 - 253
